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Abstract
Background: The purpose of this study was to explore the diagnostic value of soluble triggering receptor
expressed on myeloid cells 1 (sTREM-1), procalcitonin (PCT), and C-reactive protein (CRP) serum levels for
differentiating sepsis from SIRS, identifying new fever caused by bacteremia, and assessing prognosis when new
fever occurred.
Methods: We enrolled 144 intensive care unit (ICU) patients: 60 with systemic inflammatory response syndrome
(SIRS) and 84 with sepsis complicated by new fever at more than 48 h after ICU admission. Serum sTREM-1, PCT,
and CRP levels were measured on the day of admission and at the occurrence of new fever (>38.3°C) during
hospitalization. Based on the blood culture results, the patients were divided into a blood culture-positive
bacteremia group (33 patients) and blood culture-negative group (51 patients). Based on 28-day survival, all
patients, both blood culture-positive and -negative, were further divided into survivor and nonsurvivor groups.
Results: On ICU day 1, the sepsis group had higher serum sTREM-1, PCT, and CRP levels compared with the SIRS
group (P <0.05). The areas under the curve (AUC) for these indicators were 0.868 (95% CI, 0.798–0.938), 0.729 (95%
CI, 0.637–0.821), and 0.679 (95% CI, 0.578–0.771), respectively. With 108.9 pg/ml as the cut-off point for serum
sTREM-1, sensitivity was 0.83 and specificity was 0.81. There was no statistically significant difference in serum
sTREM-1 or PCT levels between the blood culture-positive and -negative bacteremia groups with ICU-acquired new
fever. However, the nonsurvivors in the blood culture-positive bacteremia group had higher levels of serum
sTREM-1 and PCT (P <0.05), with a prognostic AUC for serum sTREM-1 of 0.868 (95% CI, 0.740–0.997).
(Continued on next page)
* Correspondence: xielx@263.net
†Equal contributors
1Department of Respiratory Medicine, Hainan Branch of Chinese PLA General
Hospital, Sanya, Hainan Province 572013, China
3Department of Respiratory Diseases, Chinese PLA General Hospital, Beijing
100853, China
Full list of author information is available at the end of the article
© 2012 Su et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Su et al. BMC Infectious Diseases 2012, 12:157
http://www.biomedcentral.com/1471-2334/12/157
(Continued from previous page)
Conclusions: Serum sTREM-1, PCT, and CRP levels each have a role in the early diagnosis of sepsis. Serum sTREM-1,
with the highest sensitivity and specificity of all indicators studied, is especially notable. sTREM-1, PCT, and CRP
levels are of no use in determining new fever caused by bacteremia in ICU patients, but sTREM-1 levels reflect the
prognosis of bacteremia.
Trial registration: ClinicalTrial.gov identifier NCT01410578
Keywords: Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1), Fever, Sepsis, Bacteremia, Diagnosis,
Prognosis
Background
Sepsis is one of the main causes of morbidity and mor-
tality in the intensive care unit (ICU). In the United
States, approximately 500,000 people die of sepsis each
year [1,2]. Because of the prevalence of patients with
fever, leukocytosis, and increased heart and respiratory
rates in the ICU as well as the lack of sensitivity and
specificity of these parameters, it has been a challenge
for physicians to diagnose sepsis by these criteria alone
[3,4]. Blood culture has always been held as the gold
standard for sepsis diagnosis [5]. However, treatments
are normally delayed while waiting for lab results.
Therefore, it has been a difficult task for ICU physicians
to accurately differentiate bacteremia from similar dis-
eases and come to a rapid diagnosis. In addition, clinical
studies have shown that early intervention can signifi-
cantly improve the prognosis of severe sepsis and septic
shock and lower the mortality rate [6,7]. Thus, it
becomes critical to identify any biomarker that can ac-
curately identify infection or noninfection as well as
quickly diagnose bacteremia and predict its prognosis. In
this study, we evaluated the value of soluble triggering
receptor expressed on myeloid cells 1 (sTREM-1), pro-
calcitonin (PCT), and C-reactive protein (CRP) serum
levels in terms of their value for sepsis diagnosis, identi-
fication of new fever caused by bacteremia in ICU
patients, and prediction of prognosis.
Methods
The study was performed from September 2009 to
March 2011 in the Respiratory ICU, Surgical ICU, and
Emergency ICU of the Chinese People’s Liberation Army
(CPLA) General Hospital. This study was approved by
the Ethics Committee of the CPLA General Hospital
(project No. 20090923–001) and was registered with the
U.S. National Institutes of Health Clinical Trials Registry
(NCT01410578). Patients or their family members were
fully informed and signed informed consent forms.
Inclusion and exclusion criteria
Based on the 1991 ACCP/SCCM Sepsis Directory [8]
and the diagnostic criteria advanced by the 2001 Inter-
national Sepsis Definition Conference [9], patients
exhibiting two or more of the following signs during
their first 24 h in the ICU were eligible for selection: (1)
temperature of >38°C or <36°C, (2) pulse rate of >90
beats/min, (3) respiratory rate of >20 breaths/min or
hyperventilation with a partial pressure of arterial car-
bon dioxide (PaCO2) of <32 mmHg, or (4) white blood
cell (WBC) count of >12,000μL-1 or <4000 μL-1, or
>10% immature cells. Exclusion criteria were: (1)
<18 years of age, (2) acquired immunodeficiency syn-
drome, (3) reduced polymorphonuclear granulocyte
count (<500 μL-1), or (4) died within 24 h after admis-
sion into the ICU, refused to participate in the study, or
declined treatment during the observation period.
Infection and bacteremia definition
The presence of infection, defined according to the clin-
ical and microbiological criteria of the CDC definitions
[10,11], was held as a gold standard and determined by
three independent experts who were blinded to the CRP,
PCT, and WBC results [12]. Blood culture-positive
bacteremia was defined as growth of bacteria with
recognized pathogenic capacity in one blood culture or
as growth of common skin pathogens (i.e., coagulase-
negative Staphylococcus species, diphtheroids, Bacillus
species, Propionibacterium species, or micrococci) in
two blood cultures [13].
New fever in ICUs
Fever is a common problem in ICU patients and is
mainly traced to multiple infectious or noninfectious
causes [14]. The definition of fever is arbitrary and
depends on the purpose for which it is defined. Guide-
lines for evaluation of new fever in critically ill adult
patients define fever in the ICU as a temperature of
>38.3°C [15,16]. Taking blood cultures from the patient
is the initial step in addressing fever [17]. In this study,
“new fever” refers to a new fever (temperature >38.3°C)
that occurred more than 48 h after ICU admission.
Clinical data and sample collection
Demographic and disease data of the patients admitted
to the ICU included age, gender, chief complaint upon
admission, major diagnosis, clinical manifestation, Acute
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Physiology and Chronic Health Evaluation II (APACHE
II) score, Sequential Organ Failure Assessment (SOFA)
score, WBC counts, CRP levels, PCT levels, sTREM-1
levels, cause of infection, initial disease status, and sur-
vival during the first 28 days. When the patients were
admitted to the ICU, 3 mL of intravenous blood was col-
lected within the first 24 h. The blood was centrifuged at
3000 rpm/min at 4°C for 15 min. Samples were collected
again if the patient’s temperature reached >38.3°C more
than 48 h after admission [14,17]. According to the
blood culture standards of the Clinical Laboratory Stan-
dards Institute (CLSI) [18], two sets of blood samples
were collected from two different sites and were inocu-
lated separately into a Bact/ALERT aerobic bottle and a
Bact/ALERT anaerobic bottle (bioMérieux, Marcy-l
'Etoile, France).
Serological assays and blood culture procedure
All specimens were renumbered before the experiment.
The researchers were relatively blind to each step.
sTREM-1 levels were determined in duplicate using a
double antibody sandwich enzyme-linked immunosorb-
ent assay (ELISA) (Quantikine Human TREM-1 Im-
munoassay kit; R&D Systems, Minneapolis, MN, USA).
PCT was measured using enzyme-linked fluorescence
analysis (ELFA) (VIDAS BRAHMS PCT kit; bioMér-
ieux). CRP was determined using scattering turbidimetry
(CardioPhase hsCRP; Siemens Healthcare Diagnostics,
Deerfield, IL, USA). A BacT/ALERT 3D automation sys-
tem (bioMérieux) was used to continuously monitor the
blood samples in the blood culture bottles. As soon as
bacterial growth was detected, the positive bottle was
sent for single-colony subculture. Pathogens were identi-
fied manually or using the VITEK II system, and bacter-
ial contaminants were excluded [19,20]. All procedures
were strictly conducted following the manufacturers’
instructions and standard microbiology guidelines.
Statistical analysis
SPSS statistical software v16.0 (SPSS, Chicago, IL, USA)
was used for data analysis. The normally distributed var-
iances were expressed as the mean ± SD. Student’s t-test
was used to compare mean values between two groups.
The data that were not normally distributed were
expressed as medium (interquartile ranges) and analyzed
using the rank sum test. Unordered categorical variables
were expressed as percentages, and the difference in
proportion between two groups was analyzed using the
chi-square test. A receiver operating characteristic
(ROC) curve was employed to evaluate the effects of
sTREM-1, PCT, and CRP levels on sepsis diagnosis, new




A total of 372 patients were eligible for this study. Of
these, 177 were admitted to the ICU within 24 h with
systemic inflammatory response syndrome (SIRS) cri-
teria, and 195 were excluded. The 177 patients were
divided into 57 with suspected SIRS and 120 with sus-
pected sepsis. According to microbial culture results,
these patients were further classified into two subgroups:
those with SIRS (n = 60) and those with sepsis compli-
cated with new fever (n = 84). A total of 84 patients with
sepsis were placed into either a blood culture-positive
bacteremia group (n = 33) or a blood culture-negative
group (n = 51) based on blood culture tests at the occur-
rence of new fever. Based on 28-day survivals, patients
with blood culture-positive bacteremia were further
divided into a survivor group (n = 22) and a nonsurvivor
group (n = 11), as were the patients with a negative
blood culture (29 survivors and 22 nonsurvivors). A flow
chart is shown in Figure 1.
The patients’ baseline data at admission are shown in
Table 1. Temperatures and APACHE II and SOFA scores
were notably higher in the sepsis group than in the SIRS
group (P <0.001); however, the initial temperature and
APACHE II and SOFA scores demonstrated no correl-
ation with blood culture-positive status. In terms of the
source of infection, the percentage of catheter-related
infections was considerably higher in the blood culture-
positive group than in the blood culture-negative group
(P= 0.006). However, pulmonary, abdominal, urinary
tract, and trauma/postoperative infections were not sig-
nificantly different between these two groups. In terms
of predisposing factors, the rate of immunosuppression
was higher in the sepsis group than in the SIRS group
(P= 0.011). Conversely, the presence or absence of im-
munosuppression in the initial stage did not correlate
with positivity of blood culture. Furthermore, there was
no significant difference in any of the other predisposing
factors among the three groups (SIRS, sepsis with blood
culture-positive bacteremia, and sepsis with a negative
blood culture). Mortality rate was much higher in the
sepsis group than in the SIRS group (P< 0.001), but this
did not correlate with blood culture positivity. No statis-
tical difference was noted for age or gender among the
three groups.
sTREM-1, CRP, and PCT: early diagnosis of sepsis on the
day of ICU admission
sTREM-1, CRP, and PCT levels and APACHE II scores
on the day of ICU admission are shown in Figure 2.
These values were significantly higher in the sepsis
group than in the SIRS group (149.06 vs. 59.97 pg/mL,
P <0.001; 2.86 vs. 0.33 ng/mL, P <0.001; 11.4 vs. 8.3
mg/dL, P= 0.001; and 18 vs. 11, P <0.001, respectively).
Su et al. BMC Infectious Diseases 2012, 12:157 Page 3 of 10
http://www.biomedcentral.com/1471-2334/12/157
On the other hand, there was no difference in WBC
counts (13.32 vs. 12.54 × 109/L, respectively; P= 0.373).
ROC curves were obtained for sTREM-1, PCT, and CRP
levels and APACHE II scores, which were significantly
different between the SIRS and sepsis groups (Figure 3).
The areas under the curve (AUC) for sTREM-1, PCT,
and CRP levels and APACHE II scores were 0.868 (95%
CI, 0.798–0.938), 0.729 (95% CI, 0.637–0.821), 0.679
(95% CI, 0.578–0.771), and 0.745 (95% CI, 0.656–0.833),
respectively. When 108.9 pg/mL was set as the cut-off
value for sTREM-1, the sensitivity was 0.83 and specifi-
city was 0.81 (Table 2).
sTREM-1, PCT, and CRP: bacteremia in patients with
sepsis and new fever
Eighty-four patients with sepsis had new fever (>38.3°C)
during their ICU stay (>48 h after ICU admission).
Thirty-three samples were positive for bacteremia
(39.2%). The causes of bacteremia are shown in Figure 4.
Among the 33 bacteremia-positive samples, 40 different
pathogens were discovered through culturing, including
22 Gram-positive bacteria: Staphylococcus aureus
(27.5%), coagulase-negative Staphylococcus (25%), and
Enterococcus (2.5%); 12 Gram-negative bacteria: Acineto-
bacter baumannii (10%), Escherichia coli (10%), and
Klebsiella pneumoniae (7.5%); and 4 Candida albicans
(10%). In addition, seven patients had co-infection of
two or more pathogens (17.5%). In a comparison be-
tween the nonbacteremia and bacteremia groups, serum
sTREM-1, PCT, and WBC counts were 155.43 (123.36)
vs. 131.57 (194.81) pg/mL, P= 0.724; 2.39 (8.1) vs. 2.71
(25) ng/ml, P= 0.693; and 12.98 ± 7.58 vs.
11.3 ± 5.01 × 109/L, P= 0.264, respectively. However, a
comparison of the CRP level between the two groups
showed a statistically significant difference (13.19 ± 8.03
vs. 9.55 ± 6.52 mg/dL, respectively; P <0.033) (Figure 5).
Figure 1 Profiles of patients enrolled in our study.
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sTREM-1, PCT, and CRP: prognostic value
We compared all parameters of the 22 survivors and the
11 nonsurvivors with a blood culture-positive status
(Table 3). Body temperature, WBC count, and sTREM-1,
PCT, and CRP levels of the nonsurvivors were higher
than those of the survivors, although only sTREM-1 and
PCT levels between the groups were significantly differ-
ent. However, in the blood culture-negative group, dif-
ferences in all of these indicators between the survivors
and nonsurvivors were insignificant. Furthermore, ROC
curves for the sTREM-1 and PCT levels to predict
bacteremia prognosis were determined (Figure 6), and
the AUC values for the sTREM-1 and PCT levels were
0.868 (95% CI, 0.740–0.997) and 0.789 (95% CI, 0.624–
0.995), respectively. With 126.9 pg/mL as the cut-off
value for sTREM-1, the sensitivity and specificity were 1
and 0.68, respectively (Table 4). Multivariable logistic re-
gression was employed to assess possible risk factors for
Table 1 Clinical and biological data at ICU admission according to SIRS and sepsis
Characteristics SIRS sepsis P value
negative blood culture positive blood culture
N=60 N=51 N=33
Age (years) 51 ± 21 59 ± 18 54 ± 20 NS
Gender (n,%) NS
Male 36 (60) 31 (60.8) 25 (75.8)
Female 24 (40) 20 (39.2) 8 (24.2)
Temperature (°C) 37.2 ± 0.9 38.4 ± 0.9 38.0 ± 1.2 <0.001
APACHE II score 11 ± 7 18± 8 17± 8 <0.001
SOFA score - 8 ± 4 8 ± 4 NS
Etiological factors (n,%)
Pulmonary infection - 40 (78.4) 23 (69.7) NS
Abdominal infection - 11 (21.6) 6 (18.2) NS
Urinary tract infection - 10 (19.6) 8 (24.2) NS
Trauma/postoperative infection - 16 (31.4) 14 (42.4) NS
Catheter-related infections - 3 (5.9) 9 (27.3) 0.006
Others - 4 (3) 1 (3) NS
Predisposing factors(n,%)
Hypertension 15 (25) 19 (37.3) 10 (30.3) NS
Diabetes 4 (6.7) 10 (19.6) 4 (12.1) NS
COPD 2 (3.3) 6 (11.8) 3 (9.1) NS
Coronary heart disease 7 (11.7) 7 (13.7) 2 (6.1) NS
Immunosuppressed 0 (0) 5 (9.8) 3 (9.1) 0.011
Nervous system disease 3 (5) 5 (5.9) 2 (6.1) NS
CKD 2 (3.3) 3 (5.9) 3 (9.1) NS
Mortality rate (n,%) 4 (6.7) 22 (43.1) 11 (33.3) P <0.001
NS, not significant. Quantitative data of normal distribution are presented as mean ± SD. Quantitative data of non-normal distribution are presented as median
(interquartile range). Qualitative data are presented as n (%).
APACHE II score Acute Physiologic Assessment and Chronic Health Evaluation II score; SOFA score Sequential Organ Failure Assessment score; COPD chronic
obstructive pulmonary disease; CKD chronic kidney disease.
Figure 2 Comparison of diagnostic values for sepsis. The diagnostic values of sTREM-1, CRP, and PCT levels; WBC count; and APACHE II score
for sepsis on the day ICU admission were compared. The dots denote individual values, and the bars denote means.
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bacteremia. The variables taken into account included
serum sTREM-1 and PCT levels. Finally, only serum
sTREM-1 was able to enter the regression equation, with
a regression coefficient of 0.007, OR of 1.007, Wald coef-
ficient of 5.716, and 95% CI of 1.001 to 1.013 (P= 0.017).
Discussion
TREM-1 is a recently discovered member of the im-
munoglobulin superfamily of receptors that is specific-
ally expressed on the surfaces of neutrophils and
monocytes. sTREM-1 is a soluble form of TREM-1 and
is released into bodily fluids when TREM-1 is upregu-
lated. Many studies have indicated that sTREM-1 could
be a valuable diagnostic biomarker for various infectious
diseases [21-28]. Dynamic changes in sTREM-1 levels
could predict survival and mortality of patients at the
early stage of sepsis [28-30]. PCT expression is related
to the severity of bacterial infection; hence, it is one of
the biomarkers for infection [31,32]. PCT measurements
along with other clinical tests for infection might be
valuable for determining the prognosis of patients
[33,34]. CRP is a biomarker involved in variety of inflam-
matory diseases. Although the majority of hospitals can
widely implement CRP analysis in sepsis diagnosis and
prognosis [35,36], whether CRP is a good biomarker for
early diagnosis of sepsis or bacteremia is still controver-
sial [37,38]. Our study found that sTREM-1, PCT, and
CRP levels indicate infection, while sTREM-1 and PCT
levels predict prognosis. However, none of these para-
meters brings to light the cause of new fever. Moreover,
sTREM-1 is the best indicator for diagnosis of sepsis and
assessment of prognosis of blood culture-positive
bacteremia.
Rivera-Chavaz et al. [39] performed a study involving
93 patients in the ICU with SIRS symptoms and sus-
pected infection. The patients were classified as having
SIRS (no infection; n = 37) or sepsis (n = 56) according to
the diagnosis of the physician in charge and clinical evi-
dence. Patients with sepsis had significantly higher
sTREM-1 levels than did those with SIRS. At a cut-off of
30 pg/mL, sTREM-1 correctly identified patients suffer-
ing from infection with 96% sensitivity and 91% specifi-
city. Porfyridis et al. [40] enrolled 68 patients with acute
respiratory illness. A total of 34 patients were diagnosed
with community-acquired bacterial pneumonia and 34
with nonbacterial pulmonary disease. sTREM-1 levels
were significantly higher in the pneumonia group than
in the nonbacterial pulmonary disease group, and this
analysis was more sensitive and specific than analysis
with CRP levels. Yong J et al. [41] performed a meta-
analysis of 13 clinical studies that fulfilled the inclusion
criteria (980 patients; 557 patients with bacterial and
423 with nonbacterial infections). They found that
sTREM-1 level for the diagnosis of infection in the AUC
of the summary ROC was 0.86, with a sensitivity of 0.82
and specificity of 0.86. This finding confirmed that
sTREM-1 is a reliable biomarker for bacterial infection.
However, other studies argue that sTREM-1 is of no
value for infection diagnosis [42-44]. Some experts have
suggested that CRP and PCT levels are more sensitive
than sTREM-1 as biomarkers for the diagnosis of bacter-
ial infection [45,46]. Our study, on the other hand, found
that on the day of ICU admission, the sepsis group had
Figure 3 ROC curves for sepsis versus SIRS. Shown are the ROC
curves for sTREM-1, CRP, and PCT levels and APACHE II score for
distinguishing sepsis from SIRS.
Table 2 Area under ROC curve as a means of differentiating sepsis from SIRS
variable AUC Std. Error P value Asymptotic 95% Confidence Interval Cut sen spe PPV NPV PLR NLR YI
Lower limit Upper limit point
sTREM-1 0.868 0.036 <0.001 0.798 0.938 108.9 0.83 0.81 0.86 0.65 2.9 0.31 0.64
PCT 0.729 0.047 <0.001 0.637 0.821 2.1 0.55 0.83 0.82 0.42 2.14 0.51 0.38
CRP 0.675 0.049 0.001 0.578 0.771 16.5 0.35 0.98 0.96 0.35 2.85 0.76 0.33
APACHEII score 0.745 0.045 <0.001 0.656 0.833 19.5 0.49 0.89 0.86 0.4 3.49 0.62 0.39
PPV Positive Predictive Value; NPV Negtive Predictive Value; PLR Positive Likelihood Ratio; NLR Negative Likelihood Ratio; YI Youden Index.
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higher sTREM-1, PCT, and CRP levels and APACHE II
scores than did the SIRS group. The indicators above, to
different degrees, have values in sepsis identification or
diagnosis, of which sTREM-1 proves most efficient. Data
obtained through our study are quite similar to those
previously reported.
There have been numerous studies on PCT. Stefan
et al. [47] enrolled 295 patients whose blood culture
samples were collected at the emergency department.
Based on the blood culture results, the patients were
categorized into blood culture-positive, blood culture-
negative, and blood culture-contaminated groups. The
results indicated that PCT is the most valuable bio-
marker for the diagnosis of sepsis and bacteremia for
patients in the emergency department. Kim et al. [48]
and Lai et al. [38,49] also arrived at the same conclusion:
that PCT levels are the most meaningful parameter for
bacteremia diagnosis and for patients with bacteremia
and a high fever in the emergency department. On the
contrary, CRP levels have no value for diagnosis of pa-
tients with bacteremia and a high fever in the emergency
department. However, Blijlevens et al. [50] questioned
the value of PCT levels in sepsis diagnosis. Ruiz-Gonzalez
et al. [51] recently suggested that sTREM-1 levels are
valuable for diagnosing bacteremia with community-
acquired pneumonia. Because fewer studies have shown
the value of sTREM-1 in the diagnosis of bacteremia, we
divided ICU patients with fever into blood culture-
positive bacteremia and blood culture-negative groups
based on their blood culture results. We found that
sTREM-1 and PCT levels in the two groups were very
comparable. Interestingly, CRP levels were significantly
higher in the blood culture-negative group than in the
bacteremia group (P= 0.033). We speculate that this
Figure 4 Causes of bacteremia. Shown are the relative proportions of causes of bacteremia from 33 positive blood cultures.
Figure 5 Comparison of diagnostic values for bacteremia. The diagnostic values of sTREM-1, CRP, and PCT levels and WBC count for
bacteremia were compared. The dots denote individual values, and the bars denote means.
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occurred because of the rise in CRP reactivity rather
than because of the bacteremia itself. Our study implies
that sTREM-1, CRP, and PCT levels may possess no
clinical value in determining whether a given septic pa-
tient is complicated with bacteremia on the grounds of a
new fever.
Gibot et al. [30] studied sTREM-1 levels in 63 patients
with severe sepsis and found that decreased sTREM-1
plasma levels were positively correlated with a better
prognosis. Thus, sTREM-1 is an excellent biomarker for
the prognosis of sepsis. Furthermore, our previous stud-
ies and Gibot S et al. [28-30] found that compared with
PCT and CRP levels, dynamic changes in sTREM-1
levels better predict the prognosis of sepsis. However, no
studies have reported whether sTREM-1, PCT, or CRP
levels are good parameters for the prognosis of
bacteremia. We herein showed that sTREM-1 and PCT
levels were useful for the prognosis of blood culture-
positive bacteremia. For example, within the bacteremia
group, sTREM-1 and PCT levels were significantly
higher in nonsurvivors than in survivors. However, we
failed to find any prognostic value of sTREM-1 or PCT
for blood culture-negative sepsis. Moreover, according to
the ROC curves of sTREM-1 and PCT levels, sTREM-1
is a more ideal predictor for the prognosis of blood
culture-positive bacteremia. Thus, physicians are
expected to pay close attention to patients with high
levels of sTREM-1.
Our study was, however, limited by the following fac-
tors. (1) The study involved a small sample size; only 33
patients with a positive blood culture were enrolled. (2)
Only those who developed a new fever (>38.3°C) in the
ICU were enrolled. Therefore, we cannot exclude the
possibility that patients who did not have a high fever
also had bacteremia; unfortunately, however, no such
patients were involved in our analyses. (3) The incidence
of opportunistic infections is higher in the ICU, and
many pathogens circulate in the wards. Consequently,
the possibility of false-positive blood cultures could not
be excluded. Furthermore, the patients received regular
antibiotic treatments, and side effects of such a long-
term treatment should not have been ignored. (4) It is
well known that more than two-thirds of patients with
severe bacterial sepsis have negative blood cultures
[52,53], but this fact (blood culture negative bacteremia)
was not properly addressed in the study.
Conclusions
sTREM-1, PCT, and CRP levels are of substantial value
for the early diagnosis of sepsis. In addition, sTREM-1
levels can reflect the infection status more accurately
and more specifically than can CRP and PCT levels.
However, none of these three parameters could be used
to determine whether the fever of patients with sepsis
was caused by bacteremia. Finally, sTREM-1 and PCT
levels could aid in predicting the prognosis of
bacteremic patients. Regrettably, the sample size of this
study was small; larger studies are thus needed to further
Table 3 Prognostic value of temperature, WBC, and sTREM-1, CRP, and PCT levels
Parameter Blood culture-positive bacteremia P value Blood culture-negative P value
survivors non-survivors survivors non-survivors
n = 22 n=11 n=29 n=22
Temperature(mean± SD,°C)* 38.8 ± 0.5 38.9 ± 0.7 0.559 39.0 ± 0.5 38.8 ± 0.4 0.272
WBC( mean± SD, ×10∧9/L)* 10.8 ± 3.6 12.2 ± 7.2 0.559 12.7 ± 8.0 13.4 ± 7.1 0.747
sTREM-1(median-interquartile range, pg/ml)# 105.6(90.8) 273.6(350.6) 0.004 137.1(159.2) 168.3(150.2) 0.068
PCT (median-interquartile range, ng/ml)# 1.2(11.4) 19.9(61.7) 0.011 2.6(6.8) 1.8(9.6) 0.622
CRP(median-interquartile range, mg/dl)* 8.9 ± 7.1 10.9 ± 5.2 0.408 12.6 ± 7.9 13.9 ± 8.3 0.584
*P-value, Student’s t-test.
#P-value, rank sum test.
Figure 6 ROC curves for nonsurvivors versus blood culture-
positives. Shown are the ROC curves for sTREM-1 and PCT for
distinguishing nonsurvivors from blood culture-positives.
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evaluate the value of sTREM-1, PCT, and CRP levels in
the diagnosis of bacteremia.
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